Skip to main content
SpringerLink
Log in
Book cover

Serological Cancer Markers

  • Book
  • © 1992
Download book PDF

Overview

Editors:
  1. Stewart Sell

    1. Department of Pathology and Laboratory Medicine, University of Texas Health Science Center, Houston, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Contemporary Biomedicine (CB, volume 11)

Buy print copy

Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Table of contents (25 chapters)

  1. Front Matter

    Pages i-xv
    Download chapter PDF

  2. Cancer Markers of the 1990s

    • Stewart Sell
    Pages 1-17
    Download chapter PDF

  3. Clinical Cancer Markers

    • Manfred L. Lüthgens, Peter Oehr
    Pages 19-29
    Download chapter PDF

  4. Alpha-Fetoprotein in the 1990s

    • Kazuhisa Taketa
    Pages 31-46
    Download chapter PDF

  5. Carcinoembryonic Antigen

    • Hanna M. Sikorska, Abraham Fuks, Phil Gold
    Pages 47-97
    Download chapter PDF

  6. Prostate-Specific Antigen

    • T. Ming Chu
    Pages 99-115
    Download chapter PDF

  7. Enzyme Markers

    • Doris Balinsky
    Pages 117-133
    Download chapter PDF

  8. Alkaline Phosphatases as Tumor Markers

    • Torgny Stigbrand, Britta Wahren
    Pages 135-149
    Download chapter PDF

  9. Sex-Associated Hormones

    • Shahla Masood
    Pages 151-192
    Download chapter PDF

  10. Tissue Polypeptide Antigen and Specific TPA

    • Peter Oehr, Manfred L. Lüthgens, Qian Liu
    Pages 193-206
    Download chapter PDF

  11. Tumor-Associated Carbohydrate Markers

    • Sen-itiroh Hakomori
    Pages 207-232
    Download chapter PDF

  12. Glycoamines: Structural-Functional Characterization of a New Class of Human Tumor Markers

    • Gennadi V. Glinsky
    Pages 233-260
    Download chapter PDF

  13. CA 15–3 Assay for the Detection of Episialin

    • John Hilkens
    Pages 261-280
    Download chapter PDF

  14. Clinical Applications of CA 15–3

    • Daniel F. Hayes, Carlo Tondini, Donald W. Kufe
    Pages 281-307
    Download chapter PDF

  15. CA 19–9, GICA (Gastrointestinal Cancer Antigen)

    • Rolf Lamerz
    Pages 309-339
    Download chapter PDF

  16. Mucin-Like Cancer-Associated Antigen (MCA) as Available Circulating Tumor Marker for Breast Cancer

    • Emilio Bombardieri, Massimo Gion
    Pages 341-354
    Download chapter PDF

  17. DU-PAN-2, A Clinically Useful Mucin Marker of Differentiation of Pancreatic and Other Ductal Cells and Their Tumors

    • Richard S. Metzgar, Norio Sawabu, Michael A. Hollingsworth
    Pages 355-374
    Download chapter PDF

  18. CA 50

    • Caj Haglund, Pentti Kuusela, Peter J. Roberts, Hannu Jalanko
    Pages 375-386
    Download chapter PDF

  19. TAG-72 as a Tumor Marker

    • Jeffrey Schlom, David Colcher, Diane E. Milenic, Patricia Horan Hand, John W. Greiner, Masahide Kuroki et al.
    Pages 387-416
    Download chapter PDF

  20. CA 125

    • Fredrick J. Montz
    Pages 417-427
    Download chapter PDF
Back to top

Keywords

About this book

The purpose of this book-the fourth volume of a series on Can­ cer Markers-is intended to provide an updated "status report" on today's use of cancer markers in the diagnosis and monitoring of can­ cer, with an emphasis on cancer markers detected in the serum. It has been 7 years since the publication of the last volume in this series. The 1980, 1982, and 1985 volumes covered the development of cancer markers, not only in their roles of unraveling the basic biology of can­ cer, but also as increasingly important players in the management of patients with cancer. During the last 7 years we have seen the applica­ tion of a number of markers identified by monoclonal antibodies, as well as the beginnings of the use of genetic markers defined by mo­ lecular probes. Measurements of oncogenes in tissues or cells prom­ ise many applications for the future, but as yet, these genes have not shown to be useful as serum markers of cancer. The commercial interest in serum markers for cancer, particu­ larly for the diagnosis and monitoring of tumor patients, is indicated in Chapter 24 by Owen, where the total worldwide market for cancer markers is projected to increase from $148 million in 1988 to $232 million in 1993. The degree of research interest in cancer markers is reflected in the fact that in 1988 a separate category for tumor mark­ ers was added to Index Medicus.

Editors and Affiliations

  • Department of Pathology and Laboratory Medicine, University of Texas Health Science Center, Houston, USA

    Stewart Sell

Bibliographic Information

  • Book Title: Serological Cancer Markers

  • Editors: Stewart Sell

  • Series Title: Contemporary Biomedicine

  • DOI: https://doi.org/10.1007/978-1-4612-0401-5

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 1992

  • Hardcover ISBN: 978-0-89603-209-5Published: 19 February 1992

  • Softcover ISBN: 978-1-4612-6745-4Published: 10 October 2012

  • eBook ISBN: 978-1-4612-0401-5Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XV, 536

  • Topics: Pathology

  • Industry Sectors: Biotechnology, Finance, Business & Banking, Health & Hospitals, Pharma

Publish with us

Policies and ethics

Back to top

Search

Navigation